NCT06927362 LSVT Big and Dual Task Training in Cognitive Impaired Patients
| NCT ID | NCT06927362 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Cognitive Impairment |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-04-10 |
| Primary Completion | 2025-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-04-10 with a primary completion date of 2025-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study ifs to determine the comparative effects of Lee Silverman voice treatment Big and dual task training on balance, cognition and functional mobility in older adults with cognitive impairment. Perform LSVT big four times in a week for about 4 months. Perform dual task training four times in a week for about 4 months. Complete assessments at baseline, the 4th, 8th, 12th weeks, and a follow-up at the 16th week. Outcome measures include Mini BESTest, MoCA, stroop test and time up and go test. Statistical analyses will assess within-group and between-group effects based on data distribution.
Eligibility Criteria
Inclusion Criteria: * Both male and female patients. * Age limit for patients will be above 65. * Patients with Mild and moderate cognitive impairment patients MoCA 13-25. * Patients with Berge balance scale value 41-50. * Patients who give consent to participate in study and undergo relevant test. Exclusion Criteria: * Patients with any musculoskeletal disorder in which these exercises are contraindicated. * Patients using any walking aids. * Patients with hearing impairment. * Patients with other neurological conditions with limit the patient participation in planned exercise like stroke, Parkinson's. * Patients with diagnosed psychiatric disorder or taking medication that affect cognitive function within 24 hours.
Contact & Investigator
Arooba Saeed, phD
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06927362 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Cognitive Impairment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06927362 currently recruiting?
Yes, NCT06927362 is actively recruiting participants. Contact the research team at aruba.saeed@riphah.edu.pk for enrollment information.
Where is the NCT06927362 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT06927362 clinical trial?
NCT06927362 is sponsored by Riphah International University. The principal investigator is Arooba Saeed, phD at Riphah International University. The trial plans to enroll 50 participants.